We have constructed a plasmid (pHE2) in which the synthetic human a-and 3-globin genes and the methionine aminopeptidase (Met-AP) gene from Escherichia coli are coexpressed under the control of separate tac promoters. The Hbs were expressed in E. coli JM109 and purified by fast protein liquid chromatography, producing two major components, a and b. Electrospray mass spectrometry shows that at least 98% and about 90% of the expressed a and (3 chains of component a, respectively, have the expected masses.
a and (3 chains have the correct masses without detectable N-terminal methionine (<2%). These results have been confirmed by Edman degradation studies of the amino-terminal sequences of the a and ,B chains of these two recombinant Hb (rHb) samples. rHbs from components a and b exhibit visible optical spectra identical to that of human normal adult Hb (Hb A). Component a and Hb A have very similar oxygen-binding properties, but component b shows somewhat altered oxygen binding, especially at low pH values. 1H-NMR spectra of component a and Hb A are essentially identical, whereas those of component b exhibit altered ring current-shifted and hyperfine-shifted proton resonances, indicating altered heme conformation in the (3 chain. These altered resonance patterns can be changed to those of Hb A by converting component b to the ferric state and then to the deoxy state and finally back to either the carbonmonoxy or oxy form. Thus, our E. coli expression system produces native, unmodified Hb A in high yield and can be used to produce desired mutant Hbs.
To make use of our ability to rationally design mutant human Hbs needed for research on structure-function relationships, an efficient expression system for producing unmodified human Hbs in high yields is needed. Human adult Hb (Hb A) is a tetrameric protein containing two a chains and two (3 chains having 141 and 146 amino acid residues each, respectively. Human globins and Hbs have been expressed in transgenic mice (1) (2) (3) (4) , transgenic swine (5), insect cell cultures (6) , yeast (7, 8) , and Escherichia coli (9) (10) (11) . In many respects, the E. coli system is the best choice for our purposes because of its high expression efficiency and the ease ofperforming site-directed mutagenesis. The first E. coli system to express human a-and 3-globin as a fusion protein was developed by Nagai and Th0gersen (9, 12) , but the product processing procedure is very laborious and gives low yield. Thus, this expression system has limitations, especially when large amounts of recombinant Hb (rHb) are required for biochemical-biophysical studies. Hoffman et al. (10) have reported a coexpression system in which the The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
synthetic human a-and (3-globin genes are organized in a single cistron and are expressed in equal amount. Both expressed a-and -globins are properly folded and assembled into tetrameric Hb molecules in E. coli. Hernan et al. (11) have reported the expression of a nonfusion single ,3-globin in E. coli. Although these two nonfusion systems work very well in several aspects, an extra methionine residue is retained at the N termini of both a-and ,B-globins (10, 11) . The natural N-terminal valine residues of Hb A are known to play important roles in regulating oxygen affinity, the Bohr effect, and interactions with allosteric effectors and anions (13) . The extra methionine can alter the N-terminal conformation of the Hb molecule (14) . Hence, the removal of the extra methionine residues from the N termini of both aand ,B-globins of the expressed Hb is essential before the E. coli system can be used effectively for the production of the desired mutant Hbs.
Methionine aminopeptidase (Met-AP) has been found to be responsible for the removal of the N-terminal methionine residue from a nascent peptide chain in E. coli and other organisms. The Met-AP gene has been cloned from E. coli, Salmonella, Bacillus, and yeast, and the Met-APs from a variety of organisms have been purified and characterized (15) (16) (17) (18) (19) (20) (21) . These enzymes possess unique specificity for the N-terminal methionine of a peptide or a protein (15, 22, 23) , and the Met-APs ofE. coli and Salmonella typhimurium have been reported to remove the N-terminal methionine from a number of expressed foreign proteins (15, 16) .
We have constructed a plasmid (pHE2) in which synthetic human a-and j-globin genes are coexpressed with the E. coli Met-AP gene under the control of separate tac promoters. In E. coli cells harboring this plasmid, the N-terminal methionine residues of the expressed Hb A have been effectively cleaved by the coexpressed Met-AP, and this expressed Hb A lacking the N-terminal methionines is essentially identical to the native Hb A in a number of structural and functional properties. We report here on our expression plasmid (pHE2), the isolation and purification of the expressed rHbs, and certain aspects of the structural and functional properties of these rHbs.
MATERIALS AND METHODS
Plasmids, Strain, and Media. The Hb A expression plasmid pDLIII-13e containing synthetic a-and /-globin genes was provided by Somatogen (Boulder, CO) (10) . The plasmid pSYC1174 containing the E. coli Met-AP gene was provided by Cetus (15) . E. coli JM109 was purchased from Promega. 14 ,000 rpm (Sorvall rotor GSA). The supernatant was saturated with CO gas, the pH was adjusted to 8.0 with 1 M Tris base, and 10% polyethyleneimine (vol/vol) was added to a final concentration of 0.5% to precipitate out nucleic acids. The mixture was stirred for 15 min with a stream of CO gas blowing across the top and then centrifuged at 14,000 rpm for 45 min. The supernatant was concentrated in an Amicon stirred cell concentrator, the pH was adjusted to 7.4 with dilute HCl, and the solution was dialyzed against 20 mM TrisHCl/0.1 mM triethylenetetraamine (TETA; Sigma) at pH 7.4 with several changes of buffer until the pH and conductivity of the supernatant matched those of the buffer.
Three columns were used in the final purification process using a Pharmacia fast protein liquid chromatography (FPLC) system. (i) Q-Sepharose fast flow (Pharmacia anion exchanger) (5 cm x 28 cm) with 20 mM Tris HCl/0.1 mM TETA, pH 7.4, constituted one column. About 80% of the unwanted protein bound to the resin, while Hb A was eluted in the flow-through fraction in one major band. The eluent was concentrated and dialyzed against the start buffer for the next column. (ii) The next column was Q-Sepharose fast flow (2.6 cm x 30 cm) with a gradient of 20 mM Tris HCl/0.1 mM TETA, pH 8.3, to the same buffer with 160 mM NaCl. Hb A was eluted in one major peak. The peak tubes were pooled, the pH was adjusted to 6.8 with 1 M sodium monobasic phosphate, and the protein was concentrated and then dialyzed against the starting buffer for the third column. (iii) The third column was Mono S (Pharmacia cation exchanger, HR10/10) with a gradient of 10 mM sodium phosphate/0.1 mM EDTA, pH 6.8, to 20 mM sodium phosphate/0.1 mM EDTA, pH 8.3. Recombinant Hbs were eluted in two major peaks, a and b. Total protein concentration was determined by standard Lowry assay, and the Hb concentration was determined by using published extinction coefficients (25) .
Separated a and ( chains of Hb were isolated and purified by published procedures (26, 27) .
Protein Sequencing. Automated cycles of Edman degradation were performed with an Applied Biosystems gas/liquidphase sequencer (model 470/900A) equipped with an on-line phenylthiohydantoin-amino acid analyzer (model 120A) (28) .
Mass Spectrometry. Hb samples for mass spectrometry were dialyzed extensively against distilled H20 and then lyophilized. Immediately before analysis, they were dissolved in water to give concentrations of 125 pmol of Hb per ,u1 of H20 (7.8 mg/ml). Aliquots of these solutions were then diluted to give final concentrations of 10 pmol/,ul of 50:50 water/acetonitrile containing 0.2% formic acid. Aliquots (10 ,ul) of these final solutions were introduced into the electrospray ion source at 5 ,4/min. The electrospray analyses were performed on a VG Quattro-BQ (Fisons Instruments, VG Biotech, Altrincham, U.K.), a triple quadrupole instrument with a mass range for singly charged ions of 4000. Scanning was from m/z 980 to 1400 in 10 sec per scan, and the data obtained from 20 scans were summed to give the final spectra. Mass scale calibration used the multiply charged ion peaks from the a chain (Mr = 15,126.4) ofHb A as an external reference.
Oxygen Proc. Natl. Acad. Sci. USA 90 (1993) NMR Measurements. 1H-NMR spectra were obtained on a Bruker AM-300 spectrometer operating at 300 MHz and at 29°C. All Hb samples were in 0.1 M sodium phosphate buffer (in 100% 1H20) at pH 7.0, except for the ferric-Hb samples, which were at pH 6.5. The Hb concentration range was 0.8-1.4 mM. The water signal was suppressed by using the jump-and-return pulse sequence (30) . The 1H NMR spectra of the HbCO and deoxy-Hb samples were obtained by using the proton decoupling coil of a 5-mm multinuclear probe with 90°C pulses of 9.7 ,usec, spectral widths of 8 kHz (16 kHz for deoxy-Hb), and 8000 data points. Typically 256 or 1024 scans were averaged to improve the signal-to-noise ratio. The IH NMR spectra of the ferric-Hb samples were obtained by using a 5-mm selective proton probe, with a 90°pulse width of 6 ,tsec, repetition delay of 0.5 sec, spectral width of 71.4 kHz, and 16,000 data points. Proton chemical shifts are referenced to the methyl proton resonance of the sodium salt of 2,2-dimethyl-2-silapentane-5 sulfonate (DSS) indirectly by using the water signal, which occurs at 4.76 ppm downfield from that of DSS, as the internal reference.
RESULTS
Biochemical Properties of rHbs. After purification of the expressed Hbs from the sonicate of E. coli JM109 harboring plasmid pHE2 (Fig. 1) Electrospray mass spectrometry showed that for peak a, at least 98% of the a chain of this rHb A has the same mass, within experimental error (0.005%), as the mass ofthe a chain of Hb A and about 90% of the 3 chain has the same mass as that of the , chain of Hb A (Fig. 2 A and B) . However, there was a small component (=10%) whose mass corresponds to that of normal (3 chain plus a methionine residue (Fig. 2B) . For peak b, both a and ( chains had the correct masses with undetectable (<2%) N-terminally added methionine (Fig.  2C ). These mass spectrometry results have been confirmed by Edman degradation. We investigated the oxygen-binding properties of the rHbs in peaks a and b. These two Hb components bound 02 cooperatively with a Hill coefficient similar to that of Hb A in 0.1 M phosphate at 29°C. From pH 6.8 to 8.2, thepso values and the Hill coefficients of Hb A and rHb A from peaks a and b were very similar. Below pH 6.8, the p5o values ofHb A and rHb A from peak a were very similar, whereas rHb A from peak b had somewhat lower P50 values. For example, the pso values (mmHg) at 29°C were 21.0, 20.5, and 18.0 at pH 6.0; 12.0, 13.0, and 11.0 at pH 7.0; and 7.1, 6.8, and 6.5 at pH 7.4 for Hb A, rHb A (peak a), and rHb A (peak b), respectively.
'H-NMR Studies of rHbs. 'H-NMR spectroscopy has been shown to be an excellent tool to investigate the tertiary (including the heme pockets) and quaternary (subunit interfaces) structural features ofHb A [for details, refer to a recent review by Ho (32) ]. Fig. 3 shows the ring current-shifted 'H resonances of Hb A and rHb A in the CO form. The proton resonances over the region from 0 to -2.0 ppm arose from some ofthe protons ofthe amino acid residues situated in the heme pockets ofthe Hb molecule. The ring current-shifted 'H resonances of rHbCO from peak a (Fig. 3, trace B) are identical to those of Hb A (Fig. 3, trace A) , while those from peak b (Fig. 3, trace C) Fig. 4 . There are no observable differences in the ring current-shifted 'H resonances among the isolated a chains from Hb A and rHb A from peaks a and b (Fig. 4 Left). However, the ring current-shifted 'H resonances of the isolated 3chains of rHbCO A from peak b are different (Fig.  4 Right). Thus, the conformation of the heme group in the (3 chain of the rHbCO A from peak b was altered, giving rise to altered ring current-shifted 'H resonances in the spectra of the isolated ( chains (Fig. 4 Right, trace c) and of rHbCO A from peak b (Fig. 3, trace C) .
The ferrous hyperfine-shifted and exchangeable proton resonances of Hb A and rHb A from peaks a and b in the deoxy form are shown in Fig. 5 . There are no differences in the ferrous hyperfine-shifted 'H resonances (from 11 to 24 ppm) between Hb A and rHb A from peak a-i.e., no alterations in the heme pockets between these two Hbs in the (34) . The resonance at r14 ppm has been assigned to the intersubunit hydrogen bond between a-chain Tyr42 and (3-chain Asp-99 (a characteristic feature of the deoxy quaternary structure) (34) . There is no observable difference in the resonance at =14 ppm between Hb A and rHb A from peak a in the deoxy state (Fig. 5, traces A and B) ; however, the resonance at =14 ppm in deoxy-rHb A from peak b is somewhat altered (a sharper resonance plus a high-field shoulder) (Fig. 5, trace C) .
We also investigated the very low-field 'H resonances ofHb A and rHb A from peaks a and b in the deoxy form (Fig. 6) . The resonance at =63 ppm has been assigned to the hyperfineshifted N8H-exchangeable proton of the proximal histidine residue of the a-chain of deoxy-Hb A and the one at =77 ppm has been assigned to the corresponding residue of the P chain of deoxy-Hb A (33, 35) . In Fig. 6 , there is no observable difference in the two resonances from Hb A and rHb A from peak a. On the other hand, there are two observable differences between the resonances from rHb A from peak b and Hb A: (i) the -77-ppm resonance is shifted downfield by about 1 ppm as compared with that ofHb A; and (ii) there is a shoulder at -82 ppm in the spectrum of rHb A from peak b, which is not seen in Hb A (Fig. 6 , traces A and C). We then obtained the 1H-NMR spectra of the "reconverted" Hb in both the CO and deoxy forms. Traces D in Figs. 3 and 5 show that the 1H-NMR spectra of the "reconverted" rHb A from peak b are indistinguishable from those of Hb A and rHb A from peak a (traces A and B in Figs. 3 and 5 ).
DISCUSSION
In this work, we have used the strong tac promoter to direct the expression ofE. coli Met-AP. The amount of Met-AP can be easily increased to >10% of total intracellular protein by using the tac promoter (results not shown). With the coexpression of such a large amount of E. coli Met-AP, the N-terminal methionines of the expressed a-and f3-globins were effectively removed. In experiments without Met-AP coexpression, the N-terminal methionines of both a-and f-globins were mostly not cleaved (ref. 10 ; results not shown). These results indicate that a large amount of E. coli Met-AP is necessary for the proper processing of a-and ,-globins in E. coli. Similar results have been reported for the removal of the N-terminal methionines from interleukin-2 and ricin A with the coexpressed Met-AP in E. coli (15) and S. typhimurium (16) . Hence, the relatively low content of Met-AP in normal E. coli cells may be the main cause of the failure to remove the N-terminal methionine from expressed a-and 3-globins as well as other expressed foreign proteins.
The N-terminal methionine residues of Hb produced from reticulocytes or expressed from eukaryotic systems (5-8) are entirely removed. One possibility is that the eukaryotic Met-AP possesses a higher efficiency to remove the N-terminal methionine from globin substrates. We have tried to coexpress the yeast Met-AP gene (19, 20) (1993) performance of yeast Met-AP in our E. coli system is not known.
There are two major peaks (a and b) of expressed Hb A eluted from Mono S column chromatography. Peak b has native N-terminal valine, while peak a has about 90% correct N-terminal valine and about 10% N-terminal methionine not cleaved in the 13 chain (Fig. 2) . Because of the presence of large amounts of Met-AP in our E. coli system, this incomplete processing may be related to other factors-for example, substrate-peptide folding (15) . In addition, the difficulty in processing the N-terminal methionine of,B-globin may also be related to the effect of the histidine residue in the third position (21) .
Our 1H-NMR results clearly demonstrate that there is an altered heme conformation in the P chain of rHb A from peak b, implying that the heme may not always be inserted properly in E. coli. Thus, one needs to know if the observed structural and functional perturbations in a specific recombinant mutant Hb are due to the effect of amino acid substitution or to an improper insertion of the heme into the globin molecule during in vivo assembly. According to highresolution x-ray crystallographic investigation of Hb A (37), the heme pocket of the a chain is very compact and that of the f3 chain is looser. It is tempting to speculate that there is only one possible way to insert the heme into a-globin and that there is more than one possible orientation for the insertion of a heme into f-globin because there is more room in the ,B-heme pocket to allow for this flexibility. Interestingly, when the heme iron is oxidized to the ferric state, the heme rearranges to its native conformation as in Hb A. Heme orientation disorder or heterogeneity has been reported in reconstituted Hb and Hb A, especially in azidoMetHb (38) (39) (40) . According to La Mar and coworkers (38, 39) , freshly reconstituted Hb A exists as a mixture ofisomers with individual chains possessing heme orientations differing by a 1800 rotation about the a, y-meso axis of porphyrin, with about 2% and 10% equilibrium heme disorder in the a and f8 chains of azido-MetHb, respectively. To observe the heme rotational disorder in the deoxy and CO forms of Hb A, La Mar and coworkers had to first reduce the ferric form to the corresponding ferrous state by dithionite and then to the CO form before observing the ferrous hyperfine-shifted 1H resonances for the reconverted deoxy-Hb A and the ring current-shifted 1H resonances for the reconverted HbCO A. They did not observe any abnormal 1H resonances characteristic of the so-called heme rotational disorder state in native deoxy-Hb A and HbCO A. The relationship between our 1H-NMR results for rHb A from peak b as shown in traces C of Figs. 3 and 5 and the results on the heme rotational disorder reported by others (38) (39) (40) is not clear and needs further investigation.
In conclusion, the coexpression of the Met-AP gene with synthetic human a-and f3globin genes is a simple and effective way to produce unmodified Hb A from E. coli.
However, caution must be exercised to ensure proper heme insertion into the globins to form functional hemoglobin molecules. This system will be very useful for preparing a variety of mutant hemoglobins as well as other proteins in which the native N-terminal amino acid residues are essential for their normal physiological functions.
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